| 0 |
ACROSCLEROSIS |
1 |
0.0625 |
| 1 |
INCREASED DOSE ADMINISTERED |
5 |
0.0160 |
| 2 |
INFUSION SITE COLDNESS |
1 |
0.0100 |
| 3 |
PINGUECULA |
1 |
0.0094 |
| 4 |
CONTRAST MEDIA TOXICITY |
1 |
0.0079 |
| 5 |
GADOLINIUM DEPOSITION DISEASE |
4 |
0.0072 |
| 6 |
EAR, NOSE AND THROAT DISORDER |
1 |
0.0071 |
| 7 |
SCROTAL ERYTHEMA |
1 |
0.0060 |
| 8 |
CONTRAST MEDIA REACTION |
10 |
0.0042 |
| 9 |
HEMIHYPOAESTHESIA |
1 |
0.0028 |
| 10 |
BURNING SENSATION MUCOSAL |
1 |
0.0028 |
| 11 |
VAGINAL FISTULA |
1 |
0.0028 |
| 12 |
CONTRAST MEDIA ALLERGY |
4 |
0.0022 |
| 13 |
SKIN FIBROSIS |
1 |
0.0021 |
| 14 |
DRUG CLEARANCE DECREASED |
2 |
0.0015 |
| 15 |
PARANEOPLASTIC SYNDROME |
1 |
0.0015 |
| 16 |
THROAT CLEARING |
5 |
0.0013 |
| 17 |
NEPHROGENIC SYSTEMIC FIBROSIS |
4 |
0.0013 |
| 18 |
PUSTULE |
3 |
0.0013 |
| 19 |
JOINT CONTRACTURE |
1 |
0.0009 |
| 20 |
HYPORESPONSIVE TO STIMULI |
1 |
0.0009 |
| 21 |
NASAL PRURITUS |
1 |
0.0008 |
| 22 |
TYPE IV HYPERSENSITIVITY REACTION |
2 |
0.0007 |
| 23 |
VOMITING PROJECTILE |
2 |
0.0007 |
| 24 |
UPPER RESPIRATORY TRACT CONGESTION |
2 |
0.0007 |
| 25 |
SKIN TIGHTNESS |
3 |
0.0006 |
| 26 |
PHARYNGEAL PARAESTHESIA |
1 |
0.0006 |
| 27 |
PHARYNGEAL SWELLING |
6 |
0.0006 |
| 28 |
MUSCLE CONTRACTIONS INVOLUNTARY |
2 |
0.0006 |
| 29 |
TUNNEL VISION |
1 |
0.0005 |
| 30 |
SWELLING OF EYELID |
3 |
0.0005 |
| 31 |
OROPHARYNGEAL DISCOMFORT |
4 |
0.0004 |
| 32 |
SNEEZING |
9 |
0.0004 |
| 33 |
URTICARIA |
64 |
0.0004 |
| 34 |
HYPOXIC-ISCHAEMIC ENCEPHALOPATHY |
1 |
0.0004 |
| 35 |
RETCHING |
8 |
0.0004 |
| 36 |
RESPIRATORY SYMPTOM |
1 |
0.0004 |
| 37 |
URINE ANALYSIS ABNORMAL |
1 |
0.0003 |
| 38 |
THROAT TIGHTNESS |
9 |
0.0003 |
| 39 |
FOREIGN BODY IN THROAT |
1 |
0.0003 |
| 40 |
ANAPHYLACTIC REACTION |
17 |
0.0003 |
| 41 |
MICTURITION DISORDER |
1 |
0.0003 |
| 42 |
EAR PRURITUS |
1 |
0.0003 |
| 43 |
SCLERODERMA |
1 |
0.0003 |
| 44 |
PROCEDURAL COMPLICATION |
2 |
0.0003 |
| 45 |
ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS |
2 |
0.0003 |
| 46 |
RHINITIS |
2 |
0.0002 |
| 47 |
MATERNAL EXPOSURE DURING BREAST FEEDING |
1 |
0.0002 |
| 48 |
PULSELESS ELECTRICAL ACTIVITY |
1 |
0.0002 |
| 49 |
IMMOBILE |
1 |
0.0002 |
| 50 |
PERIPHERAL COLDNESS |
3 |
0.0002 |
| 51 |
PARAESTHESIA ORAL |
3 |
0.0002 |
| 52 |
HYPERVOLAEMIA |
1 |
0.0002 |
| 53 |
THROAT IRRITATION |
9 |
0.0002 |
| 54 |
TENDERNESS |
2 |
0.0002 |
| 55 |
ASTHENOPIA |
1 |
0.0002 |
| 56 |
COLD SWEAT |
3 |
0.0002 |
| 57 |
ENERGY INCREASED |
1 |
0.0002 |
| 58 |
EYE SWELLING |
6 |
0.0002 |
| 59 |
REFUSAL OF TREATMENT BY PATIENT |
1 |
0.0002 |
| 60 |
LIP SWELLING |
5 |
0.0001 |
| 61 |
FEELING HOT |
9 |
0.0001 |
| 62 |
LYMPHOEDEMA |
1 |
0.0001 |
| 63 |
DEFAECATION URGENCY |
1 |
0.0001 |
| 64 |
IMPAIRED QUALITY OF LIFE |
2 |
0.0001 |
| 65 |
RASH PUSTULAR |
1 |
0.0001 |
| 66 |
SENSITIVE SKIN |
1 |
0.0001 |
| 67 |
CYANOSIS |
2 |
0.0001 |
| 68 |
RASH ERYTHEMATOUS |
6 |
0.0001 |
| 69 |
MUSCLE DISORDER |
1 |
0.0001 |
| 70 |
UPPER-AIRWAY COUGH SYNDROME |
1 |
0.0001 |
| 71 |
SKIN PLAQUE |
1 |
0.0001 |
| 72 |
PRURITUS |
45 |
0.0001 |
| 73 |
SKIN HYPERPIGMENTATION |
1 |
0.0001 |
| 74 |
UNRESPONSIVE TO STIMULI |
3 |
0.0001 |
| 75 |
SWELLING FACE |
7 |
0.0001 |
| 76 |
BACTERIAL INFECTION |
2 |
0.0001 |
| 77 |
SALIVARY HYPERSECRETION |
1 |
0.0001 |
| 78 |
LACRIMATION INCREASED |
3 |
0.0001 |
| 79 |
ERYTHEMA |
20 |
0.0001 |
| 80 |
SWOLLEN TONGUE |
3 |
0.0001 |
| 81 |
RASH PRURITIC |
5 |
0.0001 |
| 82 |
ASPIRATION |
1 |
0.0001 |
| 83 |
RASH PAPULAR |
2 |
0.0001 |
| 84 |
IMPAIRED DRIVING ABILITY |
1 |
0.0001 |
| 85 |
MUSCLE TWITCHING |
2 |
0.0001 |
| 86 |
HYPERSENSITIVITY |
16 |
0.0001 |
| 87 |
EYELID OEDEMA |
1 |
0.0001 |
| 88 |
SPINAL PAIN |
1 |
0.0001 |
| 89 |
INJECTION SITE EXTRAVASATION |
1 |
0.0001 |
| 90 |
VOMITING |
38 |
0.0001 |
| 91 |
GENERALISED OEDEMA |
1 |
0.0001 |
| 92 |
FLUSHING |
8 |
0.0001 |
| 93 |
CHEST DISCOMFORT |
8 |
0.0001 |
| 94 |
ADVERSE REACTION |
1 |
0.0001 |
| 95 |
BURNING SENSATION |
5 |
0.0001 |
| 96 |
OXYGEN SATURATION DECREASED |
4 |
0.0001 |
| 97 |
SINUS TACHYCARDIA |
1 |
0.0001 |
| 98 |
BRONCHOSPASM |
1 |
0.0001 |
| 99 |
PARAESTHESIA |
11 |
0.0001 |
| 100 |
MYELODYSPLASTIC SYNDROME |
1 |
0.0001 |
| 101 |
NASAL CONGESTION |
4 |
0.0001 |
| 102 |
HYPOAESTHESIA ORAL |
1 |
0.0001 |
| 103 |
TINNITUS |
3 |
0.0001 |
| 104 |
RASH |
28 |
0.0001 |
| 105 |
BRAIN FOG |
1 |
0.0001 |
| 106 |
OCULAR HYPERAEMIA |
3 |
0.0001 |
| 107 |
SENSORY DISTURBANCE |
1 |
0.0001 |
| 108 |
STAPHYLOCOCCAL INFECTION |
2 |
0.0001 |
| 109 |
VIRAL INFECTION |
2 |
0.0001 |
| 110 |
SKIN DISORDER |
2 |
0.0001 |
| 111 |
EYE PRURITUS |
2 |
0.0001 |
| 112 |
CIRCULATORY COLLAPSE |
1 |
0.0001 |
| 113 |
MUSCULOSKELETAL DISCOMFORT |
1 |
0.0001 |
| 114 |
NEUROTOXICITY |
1 |
0.0001 |
| 115 |
HEART RATE DECREASED |
2 |
0.0001 |
| 116 |
DISTURBANCE IN ATTENTION |
3 |
0.0001 |
| 117 |
LEUKOCYTOSIS |
1 |
0.0001 |
| 118 |
DYSGEUSIA |
4 |
0.0001 |
| 119 |
NAUSEA |
42 |
0.0001 |
| 120 |
DYSPHAGIA |
5 |
0.0001 |
| 121 |
BLOOD PRESSURE SYSTOLIC INCREASED |
1 |
0.0001 |
| 122 |
CYTOKINE RELEASE SYNDROME |
1 |
0.0000 |
| 123 |
ALTERED STATE OF CONSCIOUSNESS |
1 |
0.0000 |
| 124 |
TACHYCARDIA |
4 |
0.0000 |
| 125 |
RASH MACULO-PAPULAR |
1 |
0.0000 |
| 126 |
SKIN DISCOLOURATION |
2 |
0.0000 |
| 127 |
PRESYNCOPE |
1 |
0.0000 |
| 128 |
NEURALGIA |
1 |
0.0000 |
| 129 |
SYNCOPE |
4 |
0.0000 |
| 130 |
ANAPHYLACTIC SHOCK |
1 |
0.0000 |
| 131 |
DIPLOPIA |
1 |
0.0000 |
| 132 |
FEAR |
1 |
0.0000 |
| 133 |
PAIN OF SKIN |
1 |
0.0000 |
| 134 |
PALLOR |
1 |
0.0000 |
| 135 |
VISION BLURRED |
5 |
0.0000 |
| 136 |
EYE PAIN |
2 |
0.0000 |
| 137 |
DYSPHONIA |
2 |
0.0000 |
| 138 |
BONE PAIN |
2 |
0.0000 |
| 139 |
APHASIA |
1 |
0.0000 |
| 140 |
CONTRAINDICATED PRODUCT ADMINISTERED |
1 |
0.0000 |
| 141 |
VERTIGO |
2 |
0.0000 |
| 142 |
DISCOMFORT |
2 |
0.0000 |
| 143 |
INJECTION SITE RASH |
1 |
0.0000 |
| 144 |
CHEST PAIN |
6 |
0.0000 |
| 145 |
LIMB DISCOMFORT |
1 |
0.0000 |
| 146 |
SWELLING |
3 |
0.0000 |
| 147 |
DRUG-INDUCED LIVER INJURY |
1 |
0.0000 |
| 148 |
DIZZINESS |
15 |
0.0000 |
| 149 |
DYSPNOEA |
17 |
0.0000 |
| 150 |
URINARY RETENTION |
1 |
0.0000 |
| 151 |
GAIT INABILITY |
1 |
0.0000 |
| 152 |
RASH MACULAR |
1 |
0.0000 |
| 153 |
COUGH |
8 |
0.0000 |
| 154 |
HYPOAESTHESIA |
4 |
0.0000 |
| 155 |
SEIZURE |
3 |
0.0000 |
| 156 |
POLLAKIURIA |
1 |
0.0000 |
| 157 |
LOSS OF CONSCIOUSNESS |
3 |
0.0000 |
| 158 |
HYPERHIDROSIS |
3 |
0.0000 |
| 159 |
LIVER DISORDER |
1 |
0.0000 |
| 160 |
THERAPY NON-RESPONDER |
1 |
0.0000 |
| 161 |
MEMORY IMPAIRMENT |
3 |
0.0000 |
| 162 |
OROPHARYNGEAL PAIN |
2 |
0.0000 |
| 163 |
BACK PAIN |
5 |
0.0000 |
| 164 |
ABDOMINAL PAIN |
5 |
0.0000 |
| 165 |
COGNITIVE DISORDER |
1 |
0.0000 |
| 166 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
1 |
0.0000 |
| 167 |
HEART RATE INCREASED |
2 |
0.0000 |
| 168 |
HYPOTENSION |
4 |
0.0000 |
| 169 |
BLOOD PRESSURE INCREASED |
3 |
0.0000 |
| 170 |
HEADACHE |
12 |
0.0000 |
| 171 |
NERVOUSNESS |
1 |
0.0000 |
| 172 |
BLISTER |
1 |
0.0000 |
| 173 |
MUSCULAR WEAKNESS |
2 |
0.0000 |
| 174 |
CHILLS |
2 |
0.0000 |
| 175 |
PLEURAL EFFUSION |
1 |
0.0000 |
| 176 |
INFUSION RELATED REACTION |
1 |
0.0000 |
| 177 |
BLOOD PRESSURE DECREASED |
1 |
0.0000 |
| 178 |
DRY SKIN |
2 |
0.0000 |
| 179 |
MULTIPLE SCLEROSIS RELAPSE |
1 |
0.0000 |
| 180 |
ABDOMINAL PAIN UPPER |
3 |
0.0000 |
| 181 |
HYPERTENSION |
3 |
0.0000 |
| 182 |
ANXIETY |
4 |
0.0000 |
| 183 |
SKIN BURNING SENSATION |
1 |
0.0000 |
| 184 |
HOT FLUSH |
1 |
0.0000 |
| 185 |
CHRONIC KIDNEY DISEASE |
1 |
0.0000 |
| 186 |
ACUTE KIDNEY INJURY |
2 |
0.0000 |
| 187 |
CARDIAC ARREST |
1 |
0.0000 |
| 188 |
MUSCULOSKELETAL STIFFNESS |
1 |
0.0000 |
| 189 |
ADVERSE DRUG REACTION |
1 |
0.0000 |
| 190 |
MUSCLE SPASMS |
2 |
0.0000 |
| 191 |
BREAST CANCER |
1 |
0.0000 |
| 192 |
MIGRAINE |
1 |
0.0000 |
| 193 |
DRUG INTOLERANCE |
1 |
0.0000 |
| 194 |
PAIN IN EXTREMITY |
3 |
0.0000 |
| 195 |
ILLNESS |
1 |
0.0000 |
| 196 |
GENERAL PHYSICAL HEALTH DETERIORATION |
1 |
0.0000 |
| 197 |
PALPITATIONS |
1 |
0.0000 |
| 198 |
FEELING ABNORMAL |
2 |
0.0000 |
| 199 |
PRODUCT USE IN UNAPPROVED INDICATION |
2 |
0.0000 |
| 200 |
DIARRHOEA |
5 |
0.0000 |
| 201 |
ARTHRALGIA |
3 |
0.0000 |
| 202 |
INJECTION SITE PAIN |
2 |
0.0000 |
| 203 |
CONFUSIONAL STATE |
1 |
0.0000 |
| 204 |
TREMOR |
1 |
0.0000 |
| 205 |
ABDOMINAL DISCOMFORT |
1 |
0.0000 |
| 206 |
MYALGIA |
1 |
0.0000 |
| 207 |
COVID-19 |
1 |
0.0000 |
| 208 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
1 |
0.0000 |
| 209 |
PRODUCT USE ISSUE |
1 |
0.0000 |
| 210 |
ASTHENIA |
2 |
0.0000 |
| 211 |
DRUG INEFFECTIVE |
7 |
0.0000 |
| 212 |
ANAEMIA |
1 |
0.0000 |
| 213 |
SOMNOLENCE |
1 |
0.0000 |
| 214 |
PAIN |
3 |
0.0000 |
| 215 |
CONSTIPATION |
1 |
0.0000 |
| 216 |
MALAISE |
1 |
0.0000 |
| 217 |
FATIGUE |
1 |
0.0000 |
| 218 |
OFF LABEL USE |
1 |
0.0000 |